EF (37), No. (%) LF (40), No. (%) All patients (77), No. (%) C (36), No. (%) C versus all patients C versus LF EF versus LF           Χ2 P Χ2 P Χ2 P Genotype 1.323 0.5 16.1 0.0003 34.5 <0.0001 AA 1 (3) 11(27.5) 12 (16) 4 (11)             CA 7 (19) 24 (60) 31 (40) 12 (33)             CC 29 (78) 5 (12.5) 34 (44) 20 (56)             Genotype 0.3   <0.0001   <0.0001 AA/CA 8 (22) 35 (87.5) 43 (56) 16 (44)             CC 29 (78) 5 (12.5) 34 (44) 20 (56)             Genotype   0.4   0.0009   <0.0001 A 9 (12) 46 (58) 55 (36) 20 (28)             C 65 (88) 34 (42) 99 (64) 48 (72)

Table 2: Comparison of LMP7 genotype distribution and allele frequencies between HCV-infected patients with early and late fibrosis. EF: Early fibrosis (F0-F2); LF: Late fibrosis (F3-F4); C: Healthy subjects.